449 related articles for article (PubMed ID: 25915633)
1. HIV-1 and interferons: who's interfering with whom?
Doyle T; Goujon C; Malim MH
Nat Rev Microbiol; 2015 Jul; 13(7):403-13. PubMed ID: 25915633
[TBL] [Abstract][Full Text] [Related]
2. Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Fenton-May AE; Dibben O; Emmerich T; Ding H; Pfafferott K; Aasa-Chapman MM; Pellegrino P; Williams I; Cohen MS; Gao F; Shaw GM; Hahn BH; Ochsenbauer C; Kappes JC; Borrow P
Retrovirology; 2013 Dec; 10():146. PubMed ID: 24299076
[TBL] [Abstract][Full Text] [Related]
3. Production of interferons and beta-chemokines by placental trophoblasts of HIV-1-infected women.
Lee BN; Hammill H; Popek EJ; Cron S; Kozinetz C; Paul M; Shearer WT; Reuben JM
Infect Dis Obstet Gynecol; 2001; 9(2):95-104. PubMed ID: 11495560
[TBL] [Abstract][Full Text] [Related]
4. Short-Term Pegylated Interferon α2a Treatment Does Not Significantly Reduce the Viral Reservoir of Simian Immunodeficiency Virus-Infected, Antiretroviral Therapy-Treated Rhesus Macaques.
Palesch D; Bosinger SE; Mavigner M; Billingsley JM; Mattingly C; Carnathan DG; Paiardini M; Chahroudi A; Vanderford TH; Silvestri G
J Virol; 2018 Jul; 92(14):. PubMed ID: 29720521
[TBL] [Abstract][Full Text] [Related]
5. Interferons in the pathogenesis and treatment of human immunodeficiency virus infection.
Poli G; Biswas P; Fauci AS
Antiviral Res; 1994 Jul; 24(2-3):221-33. PubMed ID: 7526793
[TBL] [Abstract][Full Text] [Related]
6. Interferon α subtypes in HIV infection.
Sutter K; Dickow J; Dittmer U
Cytokine Growth Factor Rev; 2018 Apr; 40():13-18. PubMed ID: 29475588
[TBL] [Abstract][Full Text] [Related]
7. Type I Interferons in NeuroHIV.
Thaney VE; Kaul M
Viral Immunol; 2019; 32(1):7-14. PubMed ID: 30260742
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
Manion M; Rodriguez B; Medvik K; Hardy G; Harding CV; Schooley RT; Pollard R; Asmuth D; Murphy R; Barker E; Brady KE; Landay A; Funderburg N; Sieg SF; Lederman MM
PLoS One; 2012; 7(1):e30306. PubMed ID: 22291932
[TBL] [Abstract][Full Text] [Related]
9. cART Restores Transient Responsiveness to IFN Type 1 in HIV-Infected Humanized Mice.
Gruenbach M; Muller CKS; Schlaepfer E; Baroncini L; Russenberger D; Kadzioch NP; Escher B; Schlapschy M; Skerra A; Bredl S; Speck RF
J Virol; 2022 Nov; 96(21):e0082722. PubMed ID: 36250708
[TBL] [Abstract][Full Text] [Related]
10. Type I interferon upregulates Bak and contributes to T cell loss during human immunodeficiency virus (HIV) infection.
Fraietta JA; Mueller YM; Yang G; Boesteanu AC; Gracias DT; Do DH; Hope JL; Kathuria N; McGettigan SE; Lewis MG; Giavedoni LD; Jacobson JM; Katsikis PD
PLoS Pathog; 2013; 9(10):e1003658. PubMed ID: 24130482
[TBL] [Abstract][Full Text] [Related]
11. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
J Virol; 2018 May; 92(9):. PubMed ID: 29467313
[TBL] [Abstract][Full Text] [Related]
12. Interferon-inducible LY6E Protein Promotes HIV-1 Infection.
Yu J; Liang C; Liu SL
J Biol Chem; 2017 Mar; 292(11):4674-4685. PubMed ID: 28130445
[TBL] [Abstract][Full Text] [Related]
13. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
Lavender KJ; Gibbert K; Peterson KE; Van Dis E; Francois S; Woods T; Messer RJ; Gawanbacht A; Müller JA; Münch J; Phillips K; Race B; Harper MS; Guo K; Lee EJ; Trilling M; Hengel H; Piehler J; Verheyen J; Wilson CC; Santiago ML; Hasenkrug KJ; Dittmer U
J Virol; 2016 Jul; 90(13):6001-6013. PubMed ID: 27099312
[TBL] [Abstract][Full Text] [Related]
14. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
Korth MJ; Taylor MD; Katze MG
Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
[TBL] [Abstract][Full Text] [Related]
15. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
[TBL] [Abstract][Full Text] [Related]
16. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection.
Goujon C; Moncorgé O; Bauby H; Doyle T; Ward CC; Schaller T; Hué S; Barclay WS; Schulz R; Malim MH
Nature; 2013 Oct; 502(7472):559-62. PubMed ID: 24048477
[TBL] [Abstract][Full Text] [Related]
17. Plasmacytoid dendritic cells sense HIV replication before detectable viremia following treatment interruption.
Mitchell JL; Takata H; Muir R; Colby DJ; Kroon E; Crowell TA; Sacdalan C; Pinyakorn S; Puttamaswin S; Benjapornpong K; Trichavaroj R; Tressler RL; Fox L; Polonis VR; Bolton DL; Maldarelli F; Lewin SR; Haddad EK; Phanuphak P; Robb ML; Michael NL; de Souza M; Phanuphak N; Ananworanich J; Trautmann L;
J Clin Invest; 2020 Jun; 130(6):2845-2858. PubMed ID: 32017709
[TBL] [Abstract][Full Text] [Related]
18. CD4-Dependent Modulation of HIV-1 Entry by LY6E.
Yu J; Liang C; Liu SL
J Virol; 2019 Apr; 93(7):. PubMed ID: 30674630
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages.
Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig KJ; Beard MR; Suzuki K; Kelleher AD; Hertzog P; Cunningham AL
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768867
[TBL] [Abstract][Full Text] [Related]
20. Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers.
Hardy GA; Sieg S; Rodriguez B; Anthony D; Asaad R; Jiang W; Mudd J; Schacker T; Funderburg NT; Pilch-Cooper HA; Debernardo R; Rabin RL; Lederman MM; Harding CV
PLoS One; 2013; 8(2):e56527. PubMed ID: 23437155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
